Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.957
https://www.valueinhealthjournal.com/article/S1098-3015(17)31291-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
911
First Page :
A567
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31291-3&doi=10.1016/j.jval.2017.08.957